BioStock: KOL sees benefits with Stayble Therapeutics’ treatment

Stayble Therapeutics’ vision is to provide a lasting pain relief and increased function in patients with chronic disc-related back pain. To learn more about the need for new treatment alternatives for these patients, particularly in the US, BioStock got in touch with Dr. Douglas Beall who is Key Opinion Leader and member of Stayble’s Scientific Advisory Board.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/05/kol-sees-benefits-with-stayble-therapeutics-treatment/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se